TCRG
The Cannaisseur Group, Inc.0.7500
+0.4000+114%
Dec 12, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
-P/E (TTM)
-Basic EPS (TTM)
-Dividend Yield
0%Recent Filings
10-Q
10-Q
Q2 FY2025 results
The Cannaisseur Group posted no revenue for Q2 FY2025 ended June 30, 2025, matching last year but down 100% y/y for the half-year from $415, with cost of revenue dropping 41.9% y/y to $282 on lower inventory write-offs. Operating loss narrowed sharply to $77,489 from $1,070,066 y/y, thanks to 92.8% lower SG&A from reduced share-based compensation, while net loss of $79,129 edged up slightly from interest expense; the half-year net loss of $927,912 was 20% better y/y, with EPS at $(0.00) basic and diluted on 49.9M shares, consistent with no dilutive securities beyond excluded convertibles. Cash climbed to $2,558 from $563 at year-end, fueled by $90,000 in stock sales against $86,505 operating burn, leaving free cash flow negative as capex isn't disclosed; total debt stands at $112,160 including $80,000 related-party convertibles at 6.5% maturing 2025-2026 and a $27,300 EIDL at 3.75% to 2050. In August 2025, it closed an asset purchase from Sense Technologies for $965,000 cash/note, 18M Series A preferred shares, and $500,000 debt assumption, adding manufacturing IP and sensors. Yet competition squeezes CBD margins.
8-K
TCRG closes $35M asset deal
The Cannaisseur Group closed a $35 million asset acquisition from Sense Technologies and Richard Bell on August 28, 2025, adding AgTech, soy-based nutrition manufacturing, and sensor technologies to its balance sheet. This resolves its shell-risk status, paving the way for OTCQB uplisting and eventual NASDAQ candidacy, while legacy shareholders retain at least 6.5% equity. Deal terms include convertible preferred stock issuance and $500,000 debt assumption. Incoming CEO eyes partnerships amid market tailwinds, yet disclosure delinquencies linger.
10-Q
Q1 FY2025 results
The Cannaisseur Group posted no revenue in Q1 FY2025 ended March 31, 2025, down 100% y/y from $415, with cost of revenue at $164 versus $2,009 last year, yielding a gross loss of $164. Operating expenses ballooned to $846,908 from $84,196, driven by $700,000 in share-based compensation, pushing the operating loss to $847,072 from $85,790 and net loss to $848,783 from $87,330; the gap stems from that compensation hit. Diluted EPS of $(0.02) aligns with 47,878,827 weighted shares, no anti-dilution noted. Cash climbed to $20,400 on $90,000 from stock sales, funding $68,663 in operating outflows, while total debt holds at $123,160 including $91,000 in related-party convertibles at 6.5%. No free cash flow disclosed in the 10-Q. Corporate secretary resigned May 2, 2025, amid a board review. Competition squeezes CBD margins further.
8-K
Shareholder meeting canceled
The Cannaisseur Group canceled its informational shareholder meeting set for May 13, 2025, due to technical difficulties; the event aimed to update on a pending strategic transaction tied to an April 4 Letter of Intent. No votes were planned, but the company stays committed to transparency. It will share details via a forthcoming preliminary proxy statement after SEC review. Cancellation delays direct communication yet underscores regulatory diligence.
CBDL
CBD Life Sciences Inc.
0.00+0.00
CBDY
Target Group Inc.
0.00+0.00
CRON
Cronos Group Inc. Common Share
3.16+0.11
CURLF
Curaleaf Holdings, Inc.
4.53+0.85
KGKG
KONA GOLD BEVERAGE INC.
0.00+0.00
NXGB
NxGen Brands Inc.
0.00-0.00
PNXP
Pineapple Express Cannabis Comp
0.01+0.00
RKDA
Arcadia Biosciences, Inc.
3.64-0.03
TOBAF
TAAT Global Alternatives Inc.
0.04+0.00
YCBD
cbdMD, Inc.
1.43+0.23